Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Finance Online.
Press releases published on May 30, 2025
Bitget lista Ripple USD (RLUSD) para expandir ofertas de stablecoins no mercado à vista
GlobeNewswire
·
May 30, 2025
VICTORIA, Seicheles, May 30, 2025 (GLOBE NEWSWIRE) -- A Bitget, principal corretora de criptomoedas e empresa Web3, anunciou a listagem de Ripple USD (RLUSD) em sua plataforma de negociação à vista. RLUSD, um stablecoin de nível institucional lastreado em …
Bitget 推出 Ripple USD (RLUSD)，扩大现货市场稳定币的产品范围
GlobeNewswire
·
May 30, 2025
维多利亚，塞舌尔, May 30, 2025 (GLOBE NEWSWIRE) -- 领先的加密货币交易所和 Web3 公司 Bitget 宣布在其现货交易平台推出 Ripple USD (RLUSD)。 RLUSD 是企业级美元锚定稳定币，由 Ripple 发行。这种代币进入 Bitget 生态系统之时，正值大众对安全合规数字资产的需求持续增长之际，尤其是机构参与者和注重企业级区块链用例的开发人员。 作为与美元 1:1 挂钩的稳定币，RLUSD 原生发行于 XRP Ledger (XRPL) …
Bitget 推出 Ripple USD (RLUSD)，擴大現貨市場穩定幣的產品範圍
GlobeNewswire
·
May 30, 2025
維多利亞，塞舌爾, May 30, 2025 (GLOBE NEWSWIRE) -- 頂尖的加密貨幣交易所和 Web3 公司 Bitget 宣佈在其現貨交易平台推出 Ripple USD (RLUSD)。 RLUSD 是以美元支持的企業級穩定幣，由 Ripple 發行。這種代幣進入 Bitget 生態系統之時，正值大眾對安全合規數碼資產的需求持續增長之際，尤其是機構參與者和注重企業級區塊鏈用例的開發人員。 作為與美元 1:1 掛鉤的穩定幣，RLUSD 原生發行於 XRP Ledger (XRPL) …
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
GlobeNewswire
·
May 30, 2025
Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided …
Communiqué de presse : L’itépekimab a satisfait au critère d’évaluation principal dans l’une des deux études de phase 3 sur la BPCO
GlobeNewswire
·
May 30, 2025
L’itépekimab a satisfait au critère d’évaluation principal dans l’une des deux études de phase 3 sur la BPCO L’étude AERIFY-1 a atteint son objectif principal, à savoir une réduction statistiquement significative des exacerbations modérées ou sévères chez …
Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials
GlobeNewswire
·
May 30, 2025
AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically meaningful benefit AERIFY-2, a second Phase 3 trial, did …
Bitget Wallet Joins Solana Summit 2025 as Major Partner to Advance Crypto Payments
GlobeNewswire
·
May 30, 2025
SAN SALVADOR, El Salvador, May 30, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial crypto wallet, has announced its official partnership with the Solana Summit 2025 as a major sponsor, marking a significant step in its efforts to expand …
High Arctic Overseas Announces 2025 First Quarter Results
GlobeNewswire
·
May 30, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, May 30, 2025 (GLOBE NEWSWIRE) -- High Arctic Overseas …
Quantum eMotion Announces Brokered LIFE Financing of C$6,000,000
GlobeNewswire
·
May 30, 2025
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Quantum eMotion Corp. (“QeM” or the “Corporation”) (TSX.V: QNC; OTCQB: QNCCF) is pleased to announce a best efforts brokered …